These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 9732134)

  • 1. Classification of patients with Ménière's disease using otoacoustic emissions.
    van Huffelen WM; Mateijsen NJ; Wit HP
    Audiol Neurootol; 1998; 3(6):419-30. PubMed ID: 9732134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evoked otoacoustic emissions in patients with Ménière's disease.
    de Kleine E; Mateijsen DJ; Wit HP; Albers FW
    Otol Neurotol; 2002 Jul; 23(4):510-6. PubMed ID: 12170154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transiently evoked otoacoustic emissions in patients with Menière's disease.
    Harris FP; Probst R
    Acta Otolaryngol; 1992; 112(1):36-44. PubMed ID: 1575035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants.
    Drexl M; Krause E; Gürkov R
    Ear Hear; 2018; 39(1):42-47. PubMed ID: 28671918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in distortion product otoacoustic emissions from ears with Menière's disease.
    Kusuki M; Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Wada T; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():78-89. PubMed ID: 9879406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the differential diagnosis of Ménière's disease using low-frequency acoustic biasing of the 2f1-f2 DPOAE.
    Brown DJ; Gibson WP
    Hear Res; 2011 Dec; 282(1-2):119-27. PubMed ID: 21944944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T; Shibata T; Yamane H; Hikawa C
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of otoacoustic emission registration in the diagnosis of Meniere's disease].
    Pal'chun VT; Levina IuV
    Vestn Otorinolaringol; 1999; (6):5-8. PubMed ID: 10596591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
    Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
    Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic significance of transiently evoked otoacoustic emissions in meniere's disease].
    Li Q; Zhong N
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Oct; 13(10):435-7. PubMed ID: 12541392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audiogram fine structure and spontaneous otoacoustic emissions in patients with Menière's disease.
    Wiebe Horst J; de Kleine E
    Audiology; 1999; 38(5):267-70. PubMed ID: 10548374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of the hearing loss level and auditory sensation curve type on click evoked SP/AP amplitude ratio in Menière's disease].
    Wang Z; Shao X; Zhi B; Yan W; Lin Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):446-9. PubMed ID: 12541688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the stage of Meniere's disease using vestibular evoked myogenic potentials.
    Young YH; Huang TW; Cheng PW
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):815-8. PubMed ID: 12925337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glycerol intake and body tilt on otoacoustic emissions reflect labyrinthine pressure changes in Menière's disease.
    Mom T; Gilain L; Avan P
    Hear Res; 2009 Apr; 250(1-2):38-45. PubMed ID: 19450433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency analysis of evoked otoacoustic emissions in Meniére's disease.
    Kubo T; Sakashita T; Kusuki M; Nakai Y
    Acta Otolaryngol Suppl; 1995; 519():275-81. PubMed ID: 7610886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unstable distortion-product otoacoustic emission phase in Menière's disease.
    Avan P; Giraudet F; Chauveau B; Gilain L; Mom T
    Hear Res; 2011 Jul; 277(1-2):88-95. PubMed ID: 21426928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular vestibular evoked myogenic potentials: frequency tuning to air-conducted acoustic stimuli in healthy subjects and Ménière's disease.
    Winters SM; Berg IT; Grolman W; Klis SF
    Audiol Neurootol; 2012; 17(1):12-9. PubMed ID: 21540585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.